{"id":"https://openalex.org/W2963857964","doi":"https://doi.org/10.1186/s41687-019-0140-3","title":"Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire","display_name":"Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire","publication_year":2019,"publication_date":"2019-07-23","ids":{"openalex":"https://openalex.org/W2963857964","doi":"https://doi.org/10.1186/s41687-019-0140-3","mag":"2963857964","pmid":"https://pubmed.ncbi.nlm.nih.gov/31338630","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6650510"},"language":"en","primary_location":{"id":"doi:10.1186/s41687-019-0140-3","doi":"https://doi.org/10.1186/s41687-019-0140-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s41687-019-0140-3","pdf_url":"https://jpro.springeropen.com/track/pdf/10.1186/s41687-019-0140-3","source":{"id":"https://openalex.org/S3035751226","display_name":"Journal of Patient-Reported Outcomes","issn_l":"2509-8020","issn":["2509-8020"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Patient-Reported Outcomes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jpro.springeropen.com/track/pdf/10.1186/s41687-019-0140-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077959285","display_name":"Magdalena Alicja Harrington","orcid":"https://orcid.org/0009-0006-5193-2678","observed_orcids":["https://orcid.org/0009-0006-5193-2678"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"id":"https://openalex.org/I4387155000","display_name":"Shire (United States)","ror":"https://ror.org/028dy4662","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387155000","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Magdalena Harrington","raw_affiliation_strings":["Present Address: Pfizer, 610 Main St, Cambridge, MA, 02139, USA. magdalena.a.harrington@pfizer.com","Shire (a member of the Takeda group of companies), Lexington, MA, USA. magdalena.a.harrington@pfizer.com","Shire (a member of the Takeda group of companies), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Present Address: Pfizer, 610 Main St, Cambridge, MA, 02139, USA. magdalena.a.harrington@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Shire (a member of the Takeda group of companies), Lexington, MA, USA. magdalena.a.harrington@pfizer.com","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Shire (a member of the Takeda group of companies), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I4387155000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072708002","display_name":"Asha Hareendran","orcid":"https://orcid.org/0000-0002-4608-9747","observed_orcids":["https://orcid.org/0000-0002-4608-9747"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Asha Hareendran","raw_affiliation_strings":["Evidera, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079201287","display_name":"Anne M. Skalicky","orcid":"https://orcid.org/0000-0001-9865-3824","observed_orcids":["https://orcid.org/0000-0001-9865-3824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Skalicky","raw_affiliation_strings":["Evidera, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053260972","display_name":"Hilary Wilson","orcid":"https://orcid.org/0000-0002-1102-6869","observed_orcids":["https://orcid.org/0000-0002-1102-6869"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hilary Wilson","raw_affiliation_strings":["Evidera, Bethesda, MD, USA","Present Address: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Present Address: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103646777","display_name":"Marci Clark","orcid":"https://orcid.org/0000-0002-7920-5222","observed_orcids":["https://orcid.org/0000-0002-7920-5222"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marci Clark","raw_affiliation_strings":["RTI Health Solutions, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009879675","display_name":"Jaromir Mikl","orcid":"https://orcid.org/0000-0002-5658-9809","observed_orcids":["https://orcid.org/0000-0002-5658-9809"]},"institutions":[{"id":"https://openalex.org/I4210124185","display_name":"Purdue Pharma (United States)","ror":"https://ror.org/030vvs717","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124185"]},{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"id":"https://openalex.org/I4387155000","display_name":"Shire (United States)","ror":"https://ror.org/028dy4662","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387155000","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaromir Mikl","raw_affiliation_strings":["Present Address: Purdue Pharma, Stamford, CT, USA","Shire (a member of the Takeda group of companies), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Present Address: Purdue Pharma, Stamford, CT, USA","institution_ids":["https://openalex.org/I4210124185"]},{"raw_affiliation_string":"Shire (a member of the Takeda group of companies), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I4387155000"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5077959285"],"corresponding_institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210140176","https://openalex.org/I4387155000"],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":{"value":1500,"currency":"USD","value_usd":1500},"fwci":3.9318,"has_fulltext":true,"cited_by_count":40,"citation_normalized_percentile":{"value":0.93941683,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"3","issue":"1","first_page":"44","last_page":"44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11632","display_name":"Family and Disability Support Research","score":0.022299999371170998,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13117","display_name":"Health Education and Validation","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2922","display_name":"Research and Theory"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/caregiver-burden","display_name":"caregiver burden","score":0.7210000157356262},{"id":"https://openalex.org/keywords/lysosomal-storage-disorders","display_name":"lysosomal storage disease","score":0.9789999723434448},{"id":"https://openalex.org/keywords/metachromatic-leukodystrophy","display_name":"metachromatic leukodystrophy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/hunter-syndrome","display_name":"Hunter syndrome","score":0.953000009059906},{"id":"https://openalex.org/keywords/mucopolysaccharidosis-type-iiia","display_name":"mucopolysaccharidosis type IIIA","score":0.9810000061988831},{"id":"https://openalex.org/keywords/instrument-development","display_name":"instrument development","score":0.6359999775886536},{"id":"https://openalex.org/keywords/rare-pediatric-diseases","display_name":"pediatric rare diseases","score":0.6140000224113464},{"id":"https://openalex.org/keywords/social-functioning","display_name":"social functioning","score":0.7400000095367432},{"id":"https://openalex.org/keywords/financial-impact","display_name":"financial impact","score":0.7170000076293945},{"id":"https://openalex.org/keywords/labor-productivity","display_name":"labor productivity","score":0.6669999957084656},{"id":"https://openalex.org/keywords/daily-activities","display_name":"daily activities","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C202695956","wikidata":"https://www.wikidata.org/wiki/Q2669680","display_name":"Debriefing","level":2,"score":0.6334793567657471},{"id":"https://openalex.org/C2910638406","wikidata":"https://www.wikidata.org/wiki/Q1529983","display_name":"Mucopolysaccharidosis type II","level":4,"score":0.6310886740684509},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4980001449584961},{"id":"https://openalex.org/C2776326100","wikidata":"https://www.wikidata.org/wiki/Q1120682","display_name":"Metachromatic leukodystrophy","level":2,"score":0.46440768241882324},{"id":"https://openalex.org/C2779878486","wikidata":"https://www.wikidata.org/wiki/Q25053589","display_name":"Caregiver burden","level":4,"score":0.448800653219223},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.43561357259750366},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4212011694908142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4004899263381958},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.35179784893989563},{"id":"https://openalex.org/C2779969927","wikidata":"https://www.wikidata.org/wiki/Q916766","display_name":"Enzyme replacement therapy","level":3,"score":0.34763985872268677},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2923963665962219},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.16276761889457703},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1186/s41687-019-0140-3","doi":"https://doi.org/10.1186/s41687-019-0140-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s41687-019-0140-3","pdf_url":"https://jpro.springeropen.com/track/pdf/10.1186/s41687-019-0140-3","source":{"id":"https://openalex.org/S3035751226","display_name":"Journal of Patient-Reported Outcomes","issn_l":"2509-8020","issn":["2509-8020"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Patient-Reported Outcomes","raw_type":"journal-article"},{"id":"pmid:31338630","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31338630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of patient-reported outcomes","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6650510","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6650510/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Patient Rep Outcomes","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:dbf688b2323b48aca9cb9a7be9c2f38c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dbf688b2323b48aca9cb9a7be9c2f38c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-14 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s41687-019-0140-3","doi":"https://doi.org/10.1186/s41687-019-0140-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s41687-019-0140-3","pdf_url":"https://jpro.springeropen.com/track/pdf/10.1186/s41687-019-0140-3","source":{"id":"https://openalex.org/S3035751226","display_name":"Journal of Patient-Reported Outcomes","issn_l":"2509-8020","issn":["2509-8020"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Patient-Reported Outcomes","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319659","display_name":"Shire Human Genetic Therapies","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2963857964.pdf","grobid_xml":"https://content.openalex.org/works/W2963857964.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1970390984","https://openalex.org/W1985953393","https://openalex.org/W1995749013","https://openalex.org/W2016933158","https://openalex.org/W2034511507","https://openalex.org/W2042912916","https://openalex.org/W2070227599","https://openalex.org/W2092327321","https://openalex.org/W2097368699","https://openalex.org/W2109175507","https://openalex.org/W2110147954","https://openalex.org/W2115864709","https://openalex.org/W2119593013","https://openalex.org/W2128536774","https://openalex.org/W2129388013","https://openalex.org/W2133323217","https://openalex.org/W2137890611","https://openalex.org/W2142507445","https://openalex.org/W2142743460","https://openalex.org/W2151734850","https://openalex.org/W2158919887","https://openalex.org/W2160447026","https://openalex.org/W2160726164","https://openalex.org/W2161702563","https://openalex.org/W2163220775","https://openalex.org/W2165452399","https://openalex.org/W2179366637","https://openalex.org/W2462171859","https://openalex.org/W2754304291","https://openalex.org/W4234505218","https://openalex.org/W4250968058"],"related_works":["https://openalex.org/W6958621279","https://openalex.org/W4294169037","https://openalex.org/W4205595848","https://openalex.org/W4400318162","https://openalex.org/W4312178219","https://openalex.org/W4385448265","https://openalex.org/W4392142717","https://openalex.org/W3166890818","https://openalex.org/W7133650273","https://openalex.org/W4405221434"],"abstract_inverted_index":{"BACKGROUND:":[0],"Capturing":[1],"the":[2,28,164,233,236,242],"impact":[3,29,206,225,243],"of":[4,32,76,104,116,123,163,172,179,235,244,248],"caring":[5,33,140,245],"for":[6,14,34,141,240],"patients":[7,77,249],"with":[8,36,74,79,85,93,144,250],"debilitating":[9],"rare":[10],"disease":[11,16],"is":[12,238],"important":[13],"understanding":[15],"burden.":[17],"We":[18],"aimed":[19],"to":[20,26,187],"develop":[21],"and":[22,51,68,91,108,132,156,185,222,254],"validate":[23],"an":[24,145],"instrument":[25,60],"measure":[27],"on":[30,64,119,207,246],"caregivers":[31,75,182,247],"children":[35],"three":[37],"lysosomal":[38],"storage":[39],"diseases":[40],"(LSDs):":[41],"metachromatic":[42],"leukodystrophy":[43],"(MLD),":[44],"neuronopathic":[45],"mucopolysaccharidosis":[46,52],"type":[47,53],"II":[48,87,253],"(MPS":[49,55],"II)":[50],"IIIA":[54,95],"IIIA).":[56],"METHODS:":[57],"A":[58],"draft":[59,165],"was":[61,111,126,137],"developed":[62],"based":[63,118],"targeted":[65],"literature":[66],"searches":[67],"revised":[69],"through":[70],"sequential":[71],"qualitative":[72],"interviews":[73],"first":[78],"MLD":[80],"(n":[81,88,96],"=":[82,89,97],"16),":[83],"then":[84],"MPS":[86,94,133,252,255],"22),":[90],"finally":[92],"8).":[98],"The":[99,189],"instrument,":[100],"which":[101],"covered":[102],"domains":[103],"physical,":[105],"emotional,":[106],"social":[107,148,201],"economic":[109],"burden,":[110],"refined":[112],"at":[113],"each":[114,170],"stage":[115],"development":[117],"caregiver":[120],"feedback.":[121],"Saturation":[122],"major":[124],"concepts":[125],"reached":[127],"during":[128,169],"concept":[129],"elicitation":[130],"(MLD":[131],"II).":[134],"RESULTS:":[135],"It":[136],"confirmed":[138],"that":[139,181,232],"a":[142,176],"patient":[143],"LSD":[146],"impacts":[147],"functioning,":[149,151,153],"emotional/psychological":[150,213],"physical":[152,218],"daily":[154,208],"activities,":[155],"finances/work":[157],"productivity.":[158],"Results":[159],"from":[160],"cognitive":[161],"debriefing":[162],"questionnaires":[166],"were":[167],"considered":[168],"round":[171],"interviews,":[173],"resulting":[174],"in":[175,197],"final":[177],"set":[178],"items":[180,196],"found":[183],"clear":[184],"easy":[186],"understand.":[188],"Caregiver":[190],"Impact":[191],"Questionnaire":[192],"(CIQ)":[193],"has":[194],"30":[195],"five":[198],"domains:":[199],"(1)":[200],"functioning":[202,214,219],"(7":[203],"items);":[204,211,216,221],"(2)":[205],"activities":[209],"(5":[210],"(3)":[212],"(10":[215],"(4)":[217],"(6":[220],"(5)":[223],"financial":[224],"(2":[226],"items).":[227],"CONCLUSIONS:":[228],"These":[229],"findings":[230],"demonstrate":[231],"content":[234],"CIQ":[237],"relevant":[239],"determining":[241],"MLD,":[251],"IIIA.":[256]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-07-30T00:00:00"}